ImmuPharma's total assets for Q2 2024 were £4.06M, a decrease of 0.00% from the previous quarter. GB:IMM total liabilities were £1.37M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.